title: Poliovirus RNA recombination in cell-free extracts.
abstract: Poliovirus RNA has been shown to undergo homologous genetic recombination at a high frequency in infected human cells. Recently it has become possible to mimic the entire intracellular replicative cycle of poliovirus replication in cytoplasmic extracts prepared from HeLa cells, resulting in the generation of infectious poliovirions. The mechanism of poliovirus RNA recombination has been shown previously to be coupled to RNA replication, presumably by template switching during the replication of parental RNAs. Experiments were designed to test whether recombinant poliovirus RNA molecules are produced in a cell-free environment. Recombinant molecules generated bear marker sequences that can be detected physically by reverse transcription and PCR. We report here successful detection of poliovirus RNA recombination in a cell-free replication system. The frequency measured for cell-free RNA recombination between two polymorphic marker loci 656 nt apart was between 10(-2) and 10(-3) recombinants/genome, a frequency comparable to or slightly higher than that measured for RNA recombination in infected cells.
authors.affiliation: Department of Microbiology and Immunology, Stanford University School of Medicine, California 94305-5402, USA.
authors.forename: R S
authors.initials: RS
authors.lastname: Tang
authors.forename: D J
authors.initials: DJ
authors.lastname: Barton
authors.forename: J B
authors.initials: JB
authors.lastname: Flanegan
authors.forename: K
authors.initials: K
authors.lastname: Kirkegaard
mesh_terms: D000998:Antiviral Agents / Q000494:pharmacology; D001562:Benzimidazoles / Q000494:pharmacology; D020126:Brefeldin A; D002474:Cell-Free System; D003517:Cyclopentanes; D005821:Genetic Techniques; D006367:HeLa Cells; D006801:Humans; D010091:Oximes; D017955:Poliovirus / Q000187:drug effects / Q000235:genetics*; D012367:RNA, Viral / Q000096:biosynthesis / Q000235:genetics*; D011995:Recombination, Genetic; D013449:Sulfonamides
chemical_list: D000998:Antiviral Agents; D001562:Benzimidazoles; D003517:Cyclopentanes; D010091:Oximes; D012367:RNA, Viral; D013449:Sulfonamides; D020126:Brefeldin A; C021595:viroxime